Hepatitis B and C virus infections and associated factors among HIV-positive and HIV-negative tuberculosis patients in public health facilities, Northeast Ethiopia: A comparative cross-sectional study.

Ethiopia HIV Hepatitis B virus hepatitis C virus hepatitis infection risk factor tuberculosis

Journal

SAGE open medicine
ISSN: 2050-3121
Titre abrégé: SAGE Open Med
Pays: England
ID NLM: 101624744

Informations de publication

Date de publication:
2023
Historique:
received: 22 07 2022
accepted: 13 03 2023
medline: 1 5 2023
pubmed: 1 5 2023
entrez: 1 5 2023
Statut: epublish

Résumé

Viral hepatitis, particularly hepatitis B virus and hepatitis C virus, is the leading cause of global liver-related morbidity and mortality. Concomitant infections of hepatitis B virus, hepatitis C virus, and tuberculosis are risks of hepatotoxicity and death due to antituberculosis therapy. Hepatitis and human immunodeficiency virus coinfection poses challenges in treating hepatotoxic patients and leads to mortality during antituberculosis treatment. Thus, this study aimed to determine the prevalence of hepatitis B virus and hepatitis C virus infections, and associated factors among human immunodeficiency virus-positive and human immunodeficiency virus-negative tuberculosis patients attending public health facilities, Northeast Ethiopia. A comparative cross-sectional study was conducted among 229 tuberculosis patients from January 1 to April 30, 2021 in public health facilities' tuberculosis treatment centers. Study participants were selected using a consecutive sampling technique. Data on sociodemographic and other risk factors were collected using an interviewer-based pretested questionnaire by trained data collectors. Anti-hepatitis C virus and hepatitis B surface antigen were determined in serum using enzyme-linked immunosorbent assay. Data were entered and analyzed using SPSS version 22. Logistic regression analysis was computed, and then variables with a The overall hepatitis virus infection among human immunodeficiency virus-positive and human immunodeficiency virus-negative tuberculosis patients was 14.03% and 8.14%, respectively. The prevalence of hepatitis B virus infection in human immunodeficiency virus positives and human immunodeficiency virus negatives was 10.5% and 6.4% and hepatitis C virus infection in human immunodeficiency virus positives and human immunodeficiency virus negatives was 3.5% and 1.75%, respectively. Hepatitis B virus and hepatitis C virus coinfections were not observed. Older age, history of problematic alcohol use, history of blood transfusion, ear-noise piercing, and history of multiple heterosexual partners were predictors for the hepatitis virus infection. Hepatitis virus infection increases morbidity and mortality of tuberculosis patients. Therefore, screening tuberculosis patients for hepatitis virus infection is necessary to reduce the risk of antituberculosis complications.

Identifiants

pubmed: 37123386
doi: 10.1177/20503121231166642
pii: 10.1177_20503121231166642
pmc: PMC10134168
doi:

Types de publication

Journal Article

Langues

eng

Pagination

20503121231166642

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

J Clin Virol. 2012 Aug;54(4):327-31
pubmed: 22608842
Kidney Int. 2015 May;87(5):1030-8
pubmed: 25426815
East Mediterr Health J. 2013 Jul;19(7):589-99
pubmed: 24975303
Int J Tuberc Lung Dis. 2011 Oct;15(10):1397-402
pubmed: 22283901
PLoS Pathog. 2016 Feb 18;12(2):e1005374
pubmed: 26891052
Int J Mycobacteriol. 2016 Sep;5(3):313-317
pubmed: 27847016
World J Gastroenterol. 2018 Mar 21;24(11):1216-1227
pubmed: 29568202
J Viral Hepat. 2017 Apr;24(4):312-319
pubmed: 27943542
Risk Manag Healthc Policy. 2021 Dec 01;14:4843-4852
pubmed: 34880693
Int J Infect Dis. 2014 Nov;28:95-100
pubmed: 25218771
World J Gastroenterol. 2015 Aug 7;21(29):8920-6
pubmed: 26269682
J Med Virol. 2016 Jun;88(6):996-1002
pubmed: 26580855
AIDS Behav. 2015 Mar;19(3):422-30
pubmed: 25194967
Hepat Med. 2019 Sep 06;11:137-147
pubmed: 31565003
Cancer. 2012 Sep 15;118(18):4372-84
pubmed: 22252462
BMC Nephrol. 2015 Jul 22;16:110
pubmed: 26199000
Nurs Times. 2014 Feb 12-18;110(7):12-6
pubmed: 24672908
Epidemiol Infect. 2014 Jul;142(7):1459-66
pubmed: 24067406
Transfus Clin Biol. 2017 Sep;24(3):189-195
pubmed: 28673499
Open Forum Infect Dis. 2018 Jun 16;5(7):ofy144
pubmed: 30019001
Virol J. 2020 Jul 23;17(1):113
pubmed: 32703225
PLoS One. 2013 Dec 19;8(12):e83892
pubmed: 24367617
AIDS Res Ther. 2017 Mar 8;14(1):11
pubmed: 28270215
Afr Health Sci. 2015 Jun;15(2):322-7
pubmed: 26124775
JAMA. 2008 Nov 5;300(17):2054-6
pubmed: 18984895
World J Hepatol. 2015 Jun 8;7(10):1377-89
pubmed: 26052383
BMC Res Notes. 2019 Jul 15;12(1):412
pubmed: 31307538
J Hepatol. 2013 Mar;58(3):593-608
pubmed: 23419824
BMC Infect Dis. 2019 May 3;19(1):380
pubmed: 31053100
J Clin Transl Hepatol. 2018 Sep 28;6(3):296-305
pubmed: 30271742
World J Clin Cases. 2018 Nov 6;6(13):589-599
pubmed: 30430114
Mem Inst Oswaldo Cruz. 2017 Apr;112(4):255-259
pubmed: 28327789
Int J Mol Sci. 2019 Jan 17;20(2):
pubmed: 30658519

Auteurs

Alemu Gedefie (A)

Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

Abdurahaman Seid (A)

Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

Genet Molla Fenta (G)

Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

Mihret Tilahun (M)

Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

Agumas Shibabaw (A)

Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

Abdurrahman Ali (A)

Department of Medical Laboratory Sciences, College of Medicine and Health Sciences, Wollo University, Dessie, Ethiopia.

Classifications MeSH